Directed share issue in Nordic Nanovector ASA (NO) — NOK 361 million

Carnegie acted as joint bookrunner in the directed share issue of 15,878,122 million new shares at a subscription price of NOK 22.75 per share. Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
February 2021.